The concept
Pain signals from damaged tissue are not transmitted to the central nervous system (CNS) through 'hard-wired' pathways. In contrast, nociceptive signals, once initiated, will launch a cascade of alterations in the somatosensory system, including an increase in the responsiveness of both peripheral and central neurons. These alterations will increase the response to subsequent stimuli and thus amplify pain. 1 Pre-emptive analgesia is a treatment that is initiated before and is operational during the surgical procedure in order to reduce the physiological consequences of nociceptive transmission provoked by the procedure. Owing to this 'protective' effect on the nociceptive pathways, pre-emptive analgesia has the potential to be more effective than a similar analgesic treatment initiated after surgery. Consequently, immediate postoperative pain may be reduced and the development of chronic pain may be prevented.
In this article we briefly review the scientific rationale and the clinical evidence for pre-emptive analgesia. Controversies will be discussed, and suggestions for further developments and research will be addressed.
The scientific rationale
Painful or injurious (noxious) stimuli to the body are detected by the free endings of peripheral nerves (primary afferent neurons), jointly called nociceptors. The peripheral terminals of nociceptors act as transducers, converting chemical, mechanical or thermal energy at the site of the stimulus to electrical activity, which is then conducted to the dorsal horn of the CNS (Fig. 1 ). Nociceptors are subdivided into different groups depending on their location in various tissues and their response to different stimuli. In general, the myelinated Aδ nociceptors are specialized for detecting mechanical and thermal injury and for triggering a rapid sharp pain response, termed 'first pain'. The unmyelinated C nociceptors Fig. 1 Tissue damage initiates a number of alterations of the peripheral and the central pain pathways. At the periphery, pain-promoting substances from peripheral nerve endings and extraneural sources (neurokinins, prostaglandins, serotonin, histamine) lead to sensitization of the nociceptors, resulting in altered transduction and increased conduction of nociceptive impulses towards the CNS. The barrage of pain signals from the nociceptors on the WDR neurons leads to prolonged alterations in the responsiveness of these neurons. Signals from Aδ and C fibres are amplified (hyperalgesia), and activity in Aβ fibres is interpreted as pain signals (allodynia). This central sensitization may outlast the stimuli that triggered the alterations in the first place and thus turn into a 'pain memory '. respond to strong mechanical, thermal and/or chemical stimuli, and they mediate a more delayed burning pain response, termed 'second pain'.
In the dorsal horn, the pain signals are transmitted from the nociceptors to secondary nociceptive neurons. Two classes of dorsal horn neurons are involved in the response to and further signalling of pain sensation: Nociceptive-specific (NS) neurons respond only to pain signals in Aδ and C nociceptors, whereas wide-dynamic-range (WDR) neurons respond to both non-nociceptive impulses in Aβ fibres (e.g. touch) and nociceptive impulses in Aδ and C nociceptors (Fig. 1) . A range of substances are involved in the transmission of nociceptive signals in the dorsal horn, including the excitatory amino acids aspartate and glutamate, and substance P, which acts on N-methyl-D-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. WDR neurons receive convergent input from primary afferents which supply skin, subcutaneous tissue, muscles and viscera. The activity of these neurons is determined by the convergence of excitatory and inhibitory inputs from nociceptive and non-nociceptive peripheral nerve fibres, local circuit excitatory and inhibitory neurons, and descending inputs from supraspinal sites.
Depending on the severity of the injury, external stimuli that activate nociceptors and induce pain may or may not result in overt tissue damage. Activation of nociceptors without accompanying tissue damage generally results in a consistent and proportionate relationship between the stimulus and the response. Consequently, when the stimulus that caused the pain recedes, the pain disappears without leaving any trace in the nociceptive system.
In contrast, stimuli associated with actual tissue damage initiate a number of alterations, or modulations, of both the peripheral and the central pain pathways. At the periphery, tissue damage results in a local inflammatory response with release of pain-promoting (algogenic) substances from peripheral nerve endings and extraneural sources (e.g. substance P, prostaglandins, serotonin, bradykinin and histamine) (Fig. 1) . These mediators lead to peripheral sensitization of the nociceptors, resulting in altered transduction and increased conduction of nociceptive impulses towards the CNS. In addition, the barrage of pain signals from the nociceptors onto the NS and WDR neurons in the dorsal horn leads to prolonged alterations in the responsiveness of these neurons. Signals from Aδ and C fibres will be amplified (hyperalgesia), and activity in Aβ fibres will be interpreted not as touch but as pain signals by the WDR neurons (allodynia). This central sensitization may outlast the stimuli that triggered the alterations in the first place and thus become a 'pain memory' (Fig. 1) .
In summary, pain associated with tissue damage results in prolonged modulation of the somatosensory system, with increased responsiveness of both peripheral and central pain pathways. 1 Experimental evidence suggests that it may be possible, and indeed preferable, to prevent or 'pre-empt' the neurophysiological and biochemical consequences of a noxious input to the CNS rather than to begin treatment when these consequences are already established. Accordingly, prevention of postoperative pain may be more effective than treatment.
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The clinical evidence
The idea of pain prevention was first introduced into clinical practice by Crile in 1913, 3 and further developed by Wall 4 and Woolf. 5 Based on a large body of experimental observations which suggested that analgesic interventions were more effective if they included the period of the noxious stimuli, and not just the post-injury stage, Woolf 5 suggested that 'simple changes in the timing of treatment can have profound effects on postoperative pain'.
Subsequently, these promising experimental findings were incorporated in clinical testing of the hypothesis. Because the original experimental observations suggested that timing of analgesic treatment in relation to the noxious (surgical) injury was the important issue, most studies of clinical pre-emptive analgesia have been designed to test this hypothesis. A substantial number of different analgesics or analgesic interventions have been investigated in a large number of double-blind randomized controlled trials of identical or very similar analgesic regimens initiated before versus after surgical incision, or before versus after surgical procedure. These studies include investigations of non-steroidal anti-inflammatory drugs (NSAIDs), opioids, ketamine, dextromethorphan, peripheral local anaesthetics and epidural analgesics.
A recent meta-analysis summarized the results from 80 trials involving 3761 patients, of whom 1964 received pre-emptive treatment, published between 1983 and 2000. 6 Reports that were included in this meta-analysis consisted of double-blind randomized comparisons of identical or nearly identical analgesic regimens initiated before versus after surgical incision/ procedure for postoperative pain relief with or without the use of a double dummy. Reports that were excluded included trials of comparisons of preoperative treatment with placebo treatment versus no treatment, and trials of comparisons of preoperative with preoperative plus postoperative treatment. A brief synopsis of the results of this meta-analysis is given below.
Non-steroidal anti-inflammatory drugs
Twenty trials studying various odontological, abdominal and orthopaedic procedures were identified. Some aspects of postoperative pain control were improved by pre-emptive treatment in four of the 20 trials, but no improvements were demonstrated in the remaining 16 trials. Quantitative analysis with the calculation of the weighted mean difference (WMD) of visual analogue scale (VAS) pain scores (0 = no pain; 10 = worst pain imaginable) between treatment groups was not significant in 14 trials (Fig. 2) . Overall, the meta-analysis demonstrated no analgesic benefit for pre-emptive compared with post-incisional administration of NSAIDs. 6 
Intravenous opioids
Eight trials compared pre-incisional with post-incisional administration of various opioids. The surgical procedure in all studies was abdominal hysterectomy. None of the studies demonstrated significantly reduced pain scores in the pre-emptive group. In contrast, quantitative analysis of pain scores revealed that the WMD in VAS scores between study groups was statistically significant in favour of the postoperative groups (Fig. 2) . It was concluded that no overall improvement in postoperative pain control was observed after pre-emptive administration of systemic opioids. 6 
N-methyl-D-aspartate receptor antagonists
Eight trials compared pre-versus post-incisional ketamine (six studies) or dextromethorphanin (two studies) in a variety of surgical procedures. The results of the review showed that the 'worst pain score' was significantly reduced in one trial of dextromethorphan. No effect on pain scores was observed in the other seven trials. The WMD of VAS scores were not significant (Fig. 2) . Supplementary analgesic consumption was significantly reduced by pre-emptive analgesia in three trials, but no significant effects were observed in the other five trials. The overall conclusion of the meta-analysis was that pre-emptive ketamine did not produce any improvement in postoperative pain control. Both studies on dextromethorphan were positive, but the data were too sparse for definitive conclusions to be drawn. 6 
Epidural, caudal and spinal regimens
Eighteen trials of pre-versus post-surgically initiated epidural analgesic regimens were identified. These could be divided into trials of single-dose analgesic regimens and trials of continuous analgesic regimens extending 24-72 h into the postoperative period. Furthermore, trials of caudal analgesia in children, and one trial of intrathecal anaesthesia-analgesia were analysed. 6 The single-dose epidural analgesic regimens evaluated were pre-versus post-incisional opioids (four trials), local anaesthetics (three trials), combined opioid and local anaesthetic (three trials) and a mixture of opioid and ketamine (one trial). From the quantitative meta-analysis of mean VAS pain scores it was concluded that no significant reduction by pre-emptive single-dose epidural analgesia with opioids or local anaesthetics, or a mixture of the two, could be demonstrated (Fig. 2) . However, statistically significant but generally small reductions in analgesic demand were demonstrated in seven of 11 treatment arms with pre-emptive analgesia. 6 Eight trials compared different pre-versus post-incisional continuous epidural regimens that extended 24-72 h into the postoperative period. The regimens included various mixtures of opioid, local anaesthetic and ketamine. The results from the meta-analysis showed no overall improvement in postoperative pain relief with pre-emptive continuous epidural analgesia (Fig. 2) .
Finally, pre-emptive treatment was ineffective in four of five studies of caudal block and in the single study of intrathecal block. 6 
Peripheral local anaesthetics
Twenty trials comparing pre-emptive with post-incisional application of peripheral local anaesthetics were analysed. These were divided into trials of wound infiltration, peripheral nerve block and intraperitoneal infiltration.
Sixteen trials compared preoperative incisional local anaesthetics with similar post-incisional administration. Quantitative analysis was possible for 14 of these trials. The WMD of VAS pain scores between treatment groups was not significant (Fig. 2) . It was concluded that there was no evidence for improved pain relief with pre-emptive local anaesthetic wound infiltration compared with a similar post-incisional administration.
Three trials investigated different nerve blocks but found no overall beneficial effects of the pre-emptive regimens. However, pain scores and demand for supplementary ketorolac were reduced in the pre-emptive treatment group in one trial of topical intraperitoneal bupivacaine. 6 Update on studies of pre-emptive analgesia in acute pain A search on Medline (www.ncbi.nlm.nih.gov/PubMed/) for the period 2001-2004, using the search term 'preemptive analgesia OR pre-emptive analgesia', revealed at least 30 randomized studies of pre-versus postoperative administration of various analgesics or analgesic regimens 7-36 that had been published since the meta-analysis performed by Møiniche et al. 6 A brief summary of the major endpoints of these trials is shown in Table 1 . Some reductions in postoperative pain and/or analgesic requirements with pre-emptive analgesia were observed in 13 studies, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] whereas no significant differences were observed in 17 other studies. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] In particular, the results with various NSAIDs were more positive, with six of eight studies published after 2001 showing a pre-emptive effect (Table 1 ) compared with only four of 20 studies published before 2001. 6 There is no obvious explanation for this discrepancy. In contrast, the results from studies with local anaesthetics (epidural, infiltration, nerve blocks) are almost uniformly negative (Table 1) , confirming the results of previous studies. 6 
Pre-emptive analgesia and chronic pain
It has been suggested that pre-emptive analgesia may reduce the risk of developing chronic postoperative pain. In the only trial to compare the effect of identical pre-versus post-incisional treatment on long-term pain, the percentage of patients with pain at 6 months postoperatively was significantly reduced. 37 A study of patients undergoing limb amputation, who were allocated to pre-and intraoperative epidural blockade or to an intraoperative blockade alone, assessed the occurrence of phantom limb pain for the subsequent 12 months. 38 The results showed a significant reduction in phantom limb pain 6 months postoperatively in the pre-and intraoperative group, with a non-significant similar trend 7 days and 1 year postoperatively. Unfortunately, it has not been possible to confirm these findings in subsequent controlled studies, and a recent meta-analysis concluded that 'there is little evidence from randomized trials to guide clinicians with treatment [of phantom limb pain]'. 39 
Overall conclusion on clinical evidence
Statistical improvements in postoperative pain relief following preemptive analgesia compared with post-incisional treatment have been demonstrated for some parameters or time points in 37 of 110 randomized trials. In a meta-analysis of 80 of these trials reported between 1983 and 2000 none of the quantitative analyses of WMD of average VAS pain scores recorded within 24 h after surgery showed significant improvement after the pre-emptive treatment. 6 Results from studies published between 2001 and 2004 largely confirm the results from previous studies, allthough results with NSAIDs were more positive in the later studies. However, the overall conclusion is that pre-emptive administration of analgesics in surgical patients has not proved to confer major benefits in terms of immediate postoperative pain relief or reduced need for supplemental analgesics. On the other hand, no major deleterious effects have been identified, and optimal intraoperative analgesia may still be recommended in order to blunt surgical stress response. 40 The evidence concerning the effect of pre-emptive analgesia on chronic pain states is sparse, and further research is warranted.
It should be emphasized that VAS scores and other measures of pain may be influenced by side effects and other confounding variables, and may not be reliable as the sole measure in the study of pre-emptive analgesia. Furthermore, various psychosocial variables have been shown to influence pain experience of varying duration, but they have not been evaluated in studies of pre-emptive analgesia. 26 Assessment of such factors 'may help to shed light on the processes involved in recovery from post-surgical pain'.
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The controversies
The definition of pre-emptive analgesia has varied, and this has caused confusion, misunderstanding and controversy. 2, 6, [41] [42] [43] Several papers have compared preoperative administration of analgesics with no treatment versus placebo treatment, and some of these studies have shown prolonged postoperative pain relief in patients receiving active treatment. It has been argued that the 'pre-emptive' regimens in these studies had analgesic effects that outlasted the expected clinical duration of action of the agents, and it was suggested that these effects were due to a blockade of nociceptive impulses during surgery, resulting in a reduction of central sensitization (Fig. 3D) . A positive result in studies designed to show that an analgesic intervention made before surgery is more effective than no intervention at all may suggest a worthwhile clinical benefit. However, these results are not evidence for or against a pre-emptive effect, since such evidence requires a control of the same intervention made at some time point after initiation of the surgical procedure. 43 As emphasized previously, the concept of pre-emptive analgesia originates from experimental studies which focus on the noxious stimulus as the trigger of central sensitization. The experimental noxious stimulus has been interpreted as the surgical incision per se by some investigators, and to the entire surgical procedure by others. Consequently, some clinical trials have compared identical or very similar analgesic regimens initiated before versus after the surgical incision, whereas others have compared before versus after the surgical procedure. A number of trials have compared continuous infusion regimens initiated before the surgical incision versus after closure of the surgical wound in order to block nociceptive transmission during the entire operation with the pre-emptive regimen (Fig. 3A-C) .
However, it is possible that none of these approaches reproduces the experimental situation. Pain can be divided by mechanism into nociceptive, inflammatory and neurogenic pain. Nociceptive pain is often regarded as the key feature of acute postoperative pain. However, in addition to incisional damage to skin and various other tissues the nociceptive barrage during surgery is followed by a protracted inflammatory state in the postoperative period, both of which may contribute to central sensitization. 41, 43 In contrast with experimental studies, where the nociceptive stimuli usually do not involve severe ongoing tissue damage, and where an analgesic intervention may block most of the afferent nociceptive input to the CNS (Fig. 4A) , the noxious stimuli occurring during and after surgery may be insufficiently reduced by conventional analgesic methods. Consequently, the single-dose regimens or even the prolonged continuous pre-emptive infusion regimens explored in clinical studies may have been inadequate (intensity and duration) to prevent or even reduce the central neuronal alterations (Fig. 4B) . Indeed, it may be difficult to prevent central sensitization in the clinical situation. There is no systematic evidence in the clinical literature to suggest that a particular pre-emptive study design (e.g. preincisional/post-incisional or pre-surgical/post-surgical) will influence a particular conclusion as to whether it supported or refuted a 'preemptive' analgesic effect. 
The future
Prevention of injury-induced functional alterations in the CNS by preemptive analgesia is a fascinating working hypothesis based on substantial scientific evidence. The hypothesis has attracted a great deal of attention, and has contributed to a substantial increase in our knowledge of the mechanisms of acute pain. Recent studies have focused on the central sensitization process itself rather than on pre-emptive analgesia, and a number of 'new' pharmacological interventions have been demonstrated to interfere with the induction and maintenance of central hypersensitivity. Ketamine, dextromethorphan and gabapentin have demonstrated promising anti-hyperalgesic potential in a number of clinical trials of postoperative pain. [44] [45] [46] Future studies should investigate the analgesic effect of combinations of different classes of 'traditional' analgesics and 'antihyperalgesics'. Furthermore, such studies should redirect their focus from the timing of perioperative analgesia to protective analgesia, 46 with the aim of preventing hypersensitivity to pain. The only way to prevent central sensitization might be to completely block any pain originating from the surgical wound from the time of incision until final wound healing. Consequently, an 'ideal' pre-emptive, or 'protective', analgesic clinical trial should investigate the effect of intense and prolonged multimodal (protective) interventions versus less aggressive conventional perioperative analgesia on immediate and late postoperative pain 6, 46 as well as on various psychosocial variables. 26 
